Capricorn Venture Partners leads £ 4.9 million investment in Green Biologics Ltd

Abingdon, UK: 2 June 2010 - Green Biologics Limited (GBL), a leading technology provider for bio-butanol production, announces the completion of an investment round of £4.9 million to roll out its technology and commercialisation plans.

The round was led by Capricorn Venture Partners, a new investor in GBL through its Capricorn Cleantech Fund, and included participation by all GBL's existing institutional investors - Morningside Ventures, Carbon Trust Investment Limited and Oxford Capital Partners - as well as by management and founder investors.

More info on the press release or on Green Biologic's website.